GW Pharmaceuticals

(NASDAQ: GWPH)
Healthcare  |  Drug Manufacturers - Major
164.92 -3.915 -2.32%
Stock Price | March 25, 2019, 3:59 p.m.
13 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 168.83
52 Week Low: 90.14
52 Week High: 182.23
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

GW Pharmaceuticals PLC is a UK based company, engaged in the research, development, and commercialization of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant. Its business activities are functioned through three reportable segments which are Commercial, Sativex Research and Development and Pipeline Research and Development. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

Read more Read less

Recently Viewed Tickers

Premium Changes to the Global Cannabis Stock Index

9 Comments
Yesterday

Premium Cannabis Stocks Review - Weekend Edition 03/25/19

60 Comments
2 days ago

Premium Weekly Review 03/22/19

5 Comments
3 days ago

Premium Cannabis Stocks Review - Weekend Edition 03/18/19

13 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 03/13/19

10 Comments
1 week ago

Premium Cannabis Stocks Review - AM Edition 03/12/19

12 Comments
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 03/11/19

6 Comments
2 weeks ago

Premium Toking Tuesday - 03/05/19

4 Comments
2 weeks ago

Premium Cannabis Stocks Review - Weekend Edition 03/04/19

18 Comments
3 weeks ago

Premium Weekly Review 03/01/19

13 Comments
3 weeks ago